Companies: 10,638     total market cap: โ‚น12178.415 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1366
Rank
โ‚น1.393 T
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น13,980
Share price
0.84%
Change (1 day)
30.58%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น383.46 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are โ‚น383.46 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น319.01 B17.86%
2023-12-31โ‚น270.67 B38.09%
2022-12-31โ‚น196.01 B27.07%
2021-12-31โ‚น154.25 B21.59%
2020-12-31โ‚น126.86 B36.22%
2019-12-31โ‚น93.13 B34.11%
2018-12-31โ‚น69.44 B33.02%
2017-12-31โ‚น52.20 B110.42%
2016-12-31โ‚น24.80 B-21.37%
2015-12-31โ‚น31.55 B104.84%
2014-12-31โ‚น15.40 B61.19%
2013-12-31โ‚น9.55 B-10.95%
2012-12-31โ‚น10.73 B46.6%
2011-12-31โ‚น7.31 B13.1%
2010-12-31โ‚น6.47 B96.95%
2009-12-31โ‚น3.28 B-42.15%
2008-12-31โ‚น5.68 B-47.68%
2007-12-31โ‚น10.85 B-37.09%
2006-12-31โ‚น17.25 B-20.61%
2005-12-31โ‚น21.74 B-3.32%
2004-12-31โ‚น22.48 B-11.01%
2003-12-31โ‚น25.26 B97.68%
2002-12-31โ‚น12.78 B-23.52%
2001-12-31โ‚น16.71 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
โ‚น262.82 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น1.739 T 353.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
โ‚น0.33 B-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น10.332 T 2,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น12.036 T 3,038.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.764 T 4,793.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น126.58 B-66.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น0.66 B-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com